38 related articles for article (PubMed ID: 12829412)
1. Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease.
Herrera A; Muñoz P; Paris I; Díaz-Veliz G; Mora S; Inzunza J; Hultenby K; Cardenas C; Jaña F; Raisman-Vozari R; Gysling K; Abarca J; Steinbusch HW; Segura-Aguilar J
Cell Mol Life Sci; 2016 Sep; 73(18):3583-97. PubMed ID: 27001668
[TBL] [Abstract][Full Text] [Related]
2. Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line.
Paris I; Muñoz P; Huenchuguala S; Couve E; Sanders LH; Greenamyre JT; Caviedes P; Segura-Aguilar J
Toxicol Sci; 2011 Jun; 121(2):376-88. PubMed ID: 21427056
[TBL] [Abstract][Full Text] [Related]
3. Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line.
Paris I; Perez-Pastene C; Cardenas S; Iturriaga-Vasquez P; Muñoz P; Couve E; Caviedes P; Segura-Aguilar J
Neurotox Res; 2010 Jul; 18(1):82-92. PubMed ID: 20087799
[TBL] [Abstract][Full Text] [Related]
4. Molecular and neurochemical mechanisms in PD pathogenesis.
Paris I; Lozano J; Perez-Pastene C; Muñoz P; Segura-Aguilar J
Neurotox Res; 2009 Oct; 16(3):271-9. PubMed ID: 19526278
[TBL] [Abstract][Full Text] [Related]
5. Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death.
Paris I; Perez-Pastene C; Couve E; Caviedes P; LeDoux S; Segura-Aguilar J
J Biol Chem; 2009 May; 284(20):13306-13315. PubMed ID: 19265190
[TBL] [Abstract][Full Text] [Related]
6. Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.
Paris I; Cardenas S; Lozano J; Perez-Pastene C; Graumann R; Riveros A; Caviedes P; Segura-Aguilar J
Neurotox Res; 2007 Sep; 12(2):125-34. PubMed ID: 17967736
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxins and neurotoxic species implicated in neurodegeneration.
Segura Aguilar J; Kostrzewa RM
Neurotox Res; 2004; 6(7-8):615-30. PubMed ID: 15639792
[TBL] [Abstract][Full Text] [Related]
8. Neurotoxicological and neuroprotective elements in Parkinson's disease.
Kostrzewa RM; Segura-Aguilar J
Neurotox Res; 2002 Mar; 4(2):83-86. PubMed ID: 12829406
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DT-diaphorase potentiates the in vivo neurotoxic effect of intranigral injection of salsolinol in rats.
Díaz-Véliz G; Mora S; Lungenstrass H; Segura-Aguilar J
Neurotox Res; 2004; 5(8):629-33. PubMed ID: 15111240
[TBL] [Abstract][Full Text] [Related]
10. On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo.
Herrera-Soto A; Díaz-Veliz G; Mora S; Muñoz P; Henny P; Steinbusch HWM; Segura-Aguilar J
Neurotox Res; 2017 Jul; 32(1):134-140. PubMed ID: 28285345
[TBL] [Abstract][Full Text] [Related]
11. A note on the inhibition of DT-diaphorase by dicoumarol.
Preusch PC; Siegel D; Gibson NW; Ross D
Free Radic Biol Med; 1991; 11(1):77-80. PubMed ID: 1718826
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DT-diaphorase is a requirement for Mn(III) to produce a 6-OH-dopamine like rotational behaviour.
Segura-Aguilar J; Diaz-Veliz G; Mora S; Herrera-Marschitz M
Neurotox Res; 2002 Mar; 4(2):127-31. PubMed ID: 12829412
[TBL] [Abstract][Full Text] [Related]
13. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.
Graumann R; Paris I; Martinez-Alvarado P; Rumanque P; Perez-Pastene C; Cardenas SP; Marin P; Diaz-Grez F; Caviedes R; Caviedes P; Segura-Aguilar J
Pol J Pharmacol; 2002; 54(6):573-9. PubMed ID: 12866711
[TBL] [Abstract][Full Text] [Related]
14. Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats.
Bustamante D; Bustamante L; Segura-Aguilar J; Goiny M; Herrera-Marschitz M
Neurotox Res; 2004; 5(8):569-77. PubMed ID: 15111234
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
